Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells

por Hanly, Elyse K., Tuli, Neha Y., Bednarczyk, Robert B., Suriano, Robert, Geliebter, Jan, Moscatello, Augustine L., Darzynkiewicz, Zbigniew, Tiwari, Raj K.
Publicado 2015

Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer

por Bednarczyk, Robert B., Tuli, Neha Y., Hanly, Elyse K., Rahoma, Ghada Ben, Maniyar, Rachana, Mittelman, Abraham, Geliebter, Jan, Tiwari, Raj K.
Publicado 2018

mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib

por Hanly, Elyse K., Bednarczyk, Robert B., Tuli, Neha Y., Moscatello, Augustine L., Halicka, H. Dorota, Li, Jiangwei, Geliebter, Jan, Darzynkiewicz, Zbigniew, Tiwari, Raj K.
Publicado 2015